循環腫瘍DNAと高リスクホルモン受容体陽性・ヒト上皮成長因子受容体2陰性乳癌における遅発再発

Lipsyc-Sharfら（Sat,）がこの問題を研究しました。

www.synapsesocial.com/papers/69d7e9bf05ee2ba81dbee86b — DOI: https://doi.org/10.1200/jco.22.00908

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits· 2014 · 149 citations
2. Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States· 2017 · 552 citations
3. Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling· 2018 · 96 citations
4. R: A Language and Environment for Statistical Computing· 2000 · 352,998 citations
5. Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network· 2012 · 696 citations